References
Tiede A (2012) Diagnosis and treatment of acquired von Willebrand syndrome. Thromb Res 130(Suppl 2):S2–S6
Franchini M, Lippi G (2007) Acquired von Willebrand syndrome: an update. Am J Hematol 82:368–375
Franchini M, Lippi G, Favaloro EJ (2010) Advances in hematology. Etiology and diagnosis of acquired von Willebrand syndrome. Clin Adv Hematol Oncol 8:20–24
Mohri H, Motomura S, Kanamori H, Matsuzaki M, Watanabe S, Maruta A, Kodama F, Okubo T (1998) Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 91:3623–3629
Tiede A, Rand JH, Budde U, Ganser A, Federici AB (2011) How I treat the acquired von Willebrand syndrome. Blood 117:6777–6785
Siaka C, Rugeri L, Caron C, Goudemand J (2003) A new ELISA assay for diagnosis of acquired von Willebrand syndrome. Haemophilia 9:303–308
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yujiri, T., Nakamura, Y., Oota, I. et al. Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance. Ann Hematol 93, 1427–1428 (2014). https://doi.org/10.1007/s00277-013-1982-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-013-1982-z